Am J Epidemiol
- BOTTA L, Capocaccia R, Bernasconi A, Rossi S, et al
The impact of cancer survivors' extra risk of noncancer mortality on net survival
estimation.
Am J Epidemiol. 2025;194:3316-3324.
Ann Surg Oncol
- BOND MJG, Bolhuis K, Linders TC, Mijnals C, et al
Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients
Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal
Cancer Liver Metastases.
Ann Surg Oncol. 2025 Nov 14. doi: 10.1245/s10434-025-18696.
- HOUBIERS A, Barbe R, Durand-Labrunie J, Bani MA, et al
ASO Author Reflections: Future Role of Radiochemotherapy in the Multimodal
Management of Retroperitoneal Lymph Node Metastases From Colorectal Cancer.
Ann Surg Oncol. 2025 Nov 17. doi: 10.1245/s10434-025-18277.
BMC Cancer
- SALGADO M, de la Camara-Gomez J, Garcia-Escobar I, Alvarez-Llosa RC, et al
Tinzaparin for the prevention of thromboembolic events in ambulatory patients
with metastatic colorectal cancer receiving first line treatment: a randomised,
clinical trial design.
BMC Cancer. 2025;25:1773.
- MANSFIELD ME, Volpi CR, John C, Adebiyi R, et al
Facilitator and barrier perspectives on learning and implementing high-resolution
anoscopy in Abuja, Nigeria: a qualitative study.
BMC Cancer. 2025;25:1766.
- WU S, Zhang Y, Lin Z, Wei M, et al
Global burden of colorectal cancer in 2022 and projections to 2050: incidence and
mortality estimates from GLOBOCAN.
BMC Cancer. 2025;25:1770.
BMC Gastroenterol
- ZHA B, Dou L, Liu Y, Zhang Y, et al
Effect of endoscopic treatment for lesions in radiotherapy field after
radiotherapy for rectal cancer.
BMC Gastroenterol. 2025;25:812.
- LI X, He Y, Yuan P, Ye Z, et al
Association between the red cell distribution Width - coefficient of variation
with colon cancer and all-cause mortality: insights from the 1999-2018 NHANES.
BMC Gastroenterol. 2025;25:813.
- YUE B, Lu Z, Zong D, Hu Y, et al
Global, regional, and national burden of early-onset and late-onset colorectal
cancer attributable to high body-mass index from 1990 to 2021: a trend analysis
and forecasts up to 2040 based on the global burden of disease study 2021.
BMC Gastroenterol. 2025;25:816.
- WU KJ, Li JC, Liu LM, Huang XJ, et al
Nitidine chloride inhibits colorectal cancer by targeting BUB1: mechanistic
insights from molecular dynamics simulation, spatial transcriptomics, and
single-cell RNA sequencing.
BMC Gastroenterol. 2025;25:818.
- DANIEL F, Hamieh N, Abdallah B, Hachicho F, et al
Compliance and yield of follow-up colonoscopy after a positive FIT in real-life
practice: a university hospital experience.
BMC Gastroenterol. 2025;25:826.
Cancer Lett
- TAN S, Chen Y, Chen Y, Liu S, et al
HOXC8-activated TRIM22/NF-kappaB Pathway Promotes Stemness in Colorectal Cancer.
Cancer Lett. 2025 Nov 18:218156. doi: 10.1016/j.canlet.2025.218156.
- TSAI YY, Chang HY, Hong WZ, Chen JY, et al
Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial
DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancer.
Cancer Lett. 2025;637:218132.
Cancer Res
- GILLETTE A, Udgata S, Schmitz AE, Stoecker JN, et al
Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment
of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids.
Cancer Res. 2025;85:4329-4340.
- MOHAMMAD MIRZAEI N, Hur C, Terry MB, Dalerba P, et al
Modeling Early-Onset Cancer Kinetics Reveals Changes in Underlying Risk and the
Impact of Population Screening.
Cancer Res. 2025;85:4558-4570.
- NATTRESS CB, O'Sullivan R, Fowler D, Hutton C, et al
Phenoscaping Reveals Multimodal gammadelta T-cell Cytotoxicity as a Strategy to Overcome
Cancer Cell-Mediated Immunomodulation.
Cancer Res. 2025;85:4415-4432.
Dis Colon Rectum
- RADEMAKER E, Aktas BC, Snaebjornsson P, de Wilt JHW, et al
Long-term Survival Outcomes of Synchronous Colon Cancer: A Cross-Sectional
Population Based Comparative Analysis.
Dis Colon Rectum. 2025 Nov 18. doi: 10.1097/DCR.0000000000004052.
Eur J Cancer
- CERVANTES B, Grosnon C, Samaille T, Mas L, et al
Patterns of progressive disease in patients with microsatellite instability-high
(MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s):
Different entities requiring tailored management.
Eur J Cancer. 2025;232:116119.
- WEISS L, Stintzing S, Modest DP, Stahler A, et al
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in
BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor
sidedness: A pooled analysis of seven clinical trials performed in the first-line
treatment of mCRC (
Eur J Cancer. 2025;232:116105.
Eur J Surg Oncol
- LAU J, Ng A, Koh WL, Lee KY, et al
The impact of colorectal cancer on quality of life of younger adults: A
qualitative longitudinal approach.
Eur J Surg Oncol. 2025;52:111169.
- XIAO C, Zhang W, Qiu M, He D, et al
A transformer-based pathomics model using endoscopic biopsy WSIs for predicting
pathological complete response to preoperative immunotherapy in colorectal
cancer.
Eur J Surg Oncol. 2025;52:111182.
Gastrointest Endosc
- VERHOEVEN DA, Basiliya K, van der Kraan J, Langers AMJ, et al
Local recurrence rates of horizontal margin-positive en bloc endoscopic
submucosal dissection of colorectal neoplasia: a meta-analysis.
Gastrointest Endosc. 2025;102:799-810.
- KWOK K, Chao C, Yan R, Attaluri V, et al
EMR versus surgery for colon adenomas and early-stage cancers: a comparative
effectiveness study.
Gastrointest Endosc. 2025;102:890-893.
- SHICHIJO S, Takeuchi Y, Kitagawa D, Ohkubo Y, et al
Safety and feasibility of intensive endoscopic interventions for delayed
perforation after colorectal endoscopic submucosal dissection (with video).
Gastrointest Endosc. 2025;102:875-880.
Int J Colorectal Dis
- GUANA R, Soto Torselli AS, De Leo F, Marino B, et al
Colorectal adenocarcinoma in children and adolescents: the management of advanced
disease.
Int J Colorectal Dis. 2025;40:237.
- SHI A, Zheng J, Wu D, Yang X, et al
Safety and feasibility of novel single-port robotic systems in colorectal cancer
surgery: a comparative study with the da Vinci Xi system.
Int J Colorectal Dis. 2025;40:236.
- LOS B, Rocha BA, da Silva DN, Ribeiro VM, et al
AI-driven pre-screening for colorectal cancer using complete blood counts: toward
broader population impact.
Int J Colorectal Dis. 2025;40:235.
- CELIK CE, Chalabiyev E, Gurler V, Onur MR, et al
Assessment of the correlation between visceral adiposity and liver fat in
metastatic colorectal cancer patients.
Int J Colorectal Dis. 2025;40:232.
- ZHANG H, Yu S, Xiang J, Mongardini FM, et al
Machine learning-based prediction model for omental metastasis in right-sided
colon cancer patients: a retrospective multicenter study.
Int J Colorectal Dis. 2025;40:233.
Int J Oncol
- SUN H, Pan Y, He B, Deng Q, et al
[Expression of Concern] Gene therapy for human colorectal cancer cell lines with
recombinant adenovirus 5 based on loss of the insulin?like growth factor 2
imprinting.
Int J Oncol. 2026;68:7.
J Am Coll Surg
- EMILE SH, Wexner SD
Discharge for Post-Acute Service After Colon Cancer Resection: A Healthcare
Disparity.
J Am Coll Surg. 2025 Nov 17. doi: 10.1097/XCS.0000000000001666.
- MYERS S, Chan WP, Davis ES, Murillo A, et al
Allocation of Post-Acute Care Services Differs Among Rural and Urban Colon Cancer
Patients After Resection.
J Am Coll Surg. 2025 Nov 17. doi: 10.1097/XCS.0000000000001663.
J Clin Oncol
- STAHLER A, Modest DP, Stintzing S, Borelli B, et al
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as
Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer.
J Clin Oncol. 2025 Nov 18:JCO2500596. doi: 10.1200/JCO-25-00596.
Lancet
- RASSCHAERT G, Tejpar S
The dawn of immunotherapy in mismatch repair proficient colorectal cancer.
Lancet. 2025;406:2302-2304.
PLoS One
- TIAN Y, Zeng Y, Liu Y, Ye J, et al
N-glycosylation of NANOG regulates stemness and apoptosis in colon cancer cells.
PLoS One. 2025;20:e0336779.
- INOUE A, Morimoto Y, Nishizawa Y, Hashimoto M, et al
Clinical utility of circulating tumor DNA for early detection of recurrence after
curative hepatectomy in patients with colorectal cancer with liver metastases: A
prospective observational study protocol (CASSIOPEIA).
PLoS One. 2025;20:e0335591.
- ADRIANTO AA, Riwanto I, Sadhana U, Paramita DK, et al
The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and
combination for colorectal cancer: A systematic review and meta-analysis.
PLoS One. 2025;20:e0307128.
Proc Natl Acad Sci U S A
-
Correction for Hao et al., Synthetical lethality of Werner helicase and mismatch
repair deficiency is mediated by p53 and PUMA in colon cancer.
Proc Natl Acad Sci U S A. 2025;122:e2529649122.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016